4.2 Review

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development

Journal

PHARMACOGENOMICS
Volume 7, Issue 7, Pages 1055-1075

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/14622416.7.7.1055

Keywords

biofluid; biomarker; clinical; mass spectrometry; metabolic profiling; metabolomics; metabonomics; nuclear magnetic resonance; pharmaceutical; statistical data analysis

Ask authors/readers for more resources

The state-of-the-art of nuclear magnetic resonance spectroscopy, mass spectrometry and statistical tools for the acquisition and evaluation of complex multidimensional spectroscopic data in metabolic profiling is reviewed in this article. The continuous evolution of the sensitivity, precision and throughput has made these technologies powerful and extremely robust tools for application in systems biology, pharmaceutical and diagnostics research. Particular emphasis is also given to the collection and storage of biological samples that are subjected to metabolite profiling. Selected examples from preclinical and clinical applications are paradigmatically shown. These illustrate the power of the profiling technologies for characterizing the metabolic phenotype of healthy, diseased and treated subjects. The complexity of disease and drug treatment is asking for an adequate response by integrated and comprehensive metabolite profiling approaches that allow the discovery of new combinations of metabolic biomarkers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available